The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Stats, 5-FU toxicity and new drug, as per Medicalnewstoday:

coloCan
coloCan CSN Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
"The National Institues of Health estimate that 275,000 patients in the United States undergo 5-FU therapy annually and 1,300 die from accidental overdoses or poor drug clearance. While no antidote for 5-FU overexposure has been approved by regulatory authorities, uridine triacetate (formerly known as vistonuridine) has been made available to physicians for emergency use."
Article is about that drug, made by Wellstat Therapeutics and 5-FU, dated 5/21.

Comments

  • This comment has been removed by the Moderator
  • KATE58
    KATE58 CSN Member Posts: 299
    unknown said:

    This comment has been removed by the Moderator

    I read an article on
    I read an article on grapefruit
    interfering with certain drugs.I looked it up
    on the internet and it said grapefruit has an ingredient
    that slows the way the liver clears toxins from the blood.
    the internet had a long list of drugs you should not ingest grapefruit
    with,one of them being xeloda. ( oral 5fu )Effects can last as long as 72 hours.
    I love grapefruit and used to eat it every morning,but now that I am on xeloda
    I forego it ( and miss it ).